Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.05 USD
Change Today -0.05 / -2.38%
Volume 51.9K
DRRX On Other Exchanges
As of 2:14 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James E. Brown D.V.M.

Co-Founder, Chief Executive Officer, President and Director,DURECT Corporation
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. James E. Brown, D.V.M. Co-founded DURECT Corporation in February 1998 and has been its President and Chief Executive Officer since June 1998. Dr. Brown served as Vice President of Biopharmaceutical and Implant Research and Development of ALZA Corporation from June 1995 to June 1998. Dr. Brown held various positions at Syntex Corporation, including Director of Business Development from May 1994 to May 1995, Director of Joint Ventures for Discovery Research from April ...

Read Full Background

Corporate Headquarters*

10260 Bubb Road
Cupertino, California 95014

United States

Phone: 408-777-1417
Fax: 408-777-3577

Board Members Memberships*

Member of Board of Directors
Co-Founder, Chief Executive Officer, President and Director


University of California, Davis
Master's Degree
University of California, Davis
San Jose State University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$470,385

Stock Options*

All Other Compensation$23,641
Exercisable Options2,107,741
Exercisable Options Value$1,857
Unexercisable Options260,770
Unexercisable Options Value$406
Total Value of Options$2,263
Total Number of Options2,368,511

Total Compensation*

Total Annual Cash Compensation$494,026
Total Short Term Compensation$470,385
Other Long Term Compensation$23,641
Total Calculated Compensation$955,726
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRRX:US $2.05 USD -0.05


Robert B. Jones Chief Executive Officer, President and Director
Acura Pharmaceuticals, Inc.
Nasrat Hakim Chief Executive Officer, President and Director
Elite Pharmaceuticals, Inc.
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
Stephen J. Farr Ph.D.Co-Founder, Chief Executive Officer, President and Director
Zogenix, Inc.
Robert S. Radie Chief Executive Officer, President and Director
Egalet Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DURECT CORPORATION, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at